708 related articles for article (PubMed ID: 20965015)
1. [Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature].
García-Rabasco AE; Esteve-Martínez A; Zaragoza-Ninet V; Sánchez-Carazo JL; Alegre-de-Miquel V
Actas Dermosifiliogr; 2010 Oct; 101(8):717-21. PubMed ID: 20965015
[TBL] [Abstract][Full Text] [Related]
2. Pyoderma gangrenosum associated with hidradenitis suppurativa.
Ah-Weng A; Langtry JA; Velangi S; Evans CD; Douglas WS
Clin Exp Dermatol; 2005 Nov; 30(6):669-71. PubMed ID: 16197385
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
Reddick CL; Singh MN; Chalmers RJ
Dermatol Online J; 2010 Aug; 16(8):15. PubMed ID: 20804692
[TBL] [Abstract][Full Text] [Related]
4. Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review.
Hsiao JL; Antaya RJ; Berger T; Maurer T; Shinkai K; Leslie KS
Arch Dermatol; 2010 Nov; 146(11):1265-70. PubMed ID: 21079064
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases.
Moschella SL
Int J Dermatol; 2007 Dec; 46(12):1287-91. PubMed ID: 18173525
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab.
Groleau PF; Grossberg AL; Gaspari AA
Cutis; 2015 Jun; 95(6):337-42. PubMed ID: 26125210
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.
Bruzzese V
J Clin Rheumatol; 2012 Dec; 18(8):413-5. PubMed ID: 23188209
[TBL] [Abstract][Full Text] [Related]
8. Pyoderma gangrenosum and concomitant hidradenitis suppurativa--rapid response to canakinumab (anti-IL-1β).
Jaeger T; Andres C; Grosber M; Zirbs M; Hein R; Ring J; Traidl-Hoffmann C
Eur J Dermatol; 2013; 23(3):408-10. PubMed ID: 23816498
[No Abstract] [Full Text] [Related]
9. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen.
Shenefelt PD
Cutis; 1996 May; 57(5):315-9. PubMed ID: 8726710
[TBL] [Abstract][Full Text] [Related]
10. Concurrent hidradenitis suppurativa, inflammatory acne, dissecting cellulitis of the scalp, and pyoderma gangrenosum in a 16-year-old boy.
Koshelev MV; Garrison PA; Wright TS
Pediatr Dermatol; 2014; 31(1):e20-1. PubMed ID: 24118007
[TBL] [Abstract][Full Text] [Related]
11. Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients.
Join-Lambert O; Duchatelet S; Delage M; Miskinyte S; Coignard H; Lemarchand N; Alemy-Carreau M; Lortholary O; Nassif X; Hovnanian A; Nassif A
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S66-9. PubMed ID: 26470620
[TBL] [Abstract][Full Text] [Related]
12. A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents.
Duchini G; Itin P; Arnold A
Adv Skin Wound Care; 2011 May; 24(5):217-20. PubMed ID: 21505282
[TBL] [Abstract][Full Text] [Related]
13. [Cutaneous pyoderma gangrenosum with hepatosplenic localization and monoclonal gammapathy. A case report].
Delbrel X; Germain P; Fach J; Etienne G; Beylot C; Parrens M; De Mascarel A; Le Bras M; Longy-Boursier M
Ann Med Interne (Paris); 2001 Feb; 152(1):65-7. PubMed ID: 11240430
[TBL] [Abstract][Full Text] [Related]
14. A case of vulvar pyoderma gangrenosum associated with collagenous colitis.
Roé E; Dalmau J; García-Navarro X; Corella F; Monfort D; Busquets D; Ribé A; Delgado E; Alomar A
Dermatology; 2006; 213(3):234-5. PubMed ID: 17033174
[TBL] [Abstract][Full Text] [Related]
15. [Pyoderma gangrenosum--clinical, laboratory and therapeutic approaches. Review of 28 cases].
Duarte AF; Nogueira A; Lisboa C; Azevedo F
Dermatol Online J; 2009 Jul; 15(7):3. PubMed ID: 19903431
[TBL] [Abstract][Full Text] [Related]
16. Pyoderma gangrenosum in a patient with bullous systemic lupus erythematosus.
Sakamoto T; Hashimoto T; Furukawa F
Eur J Dermatol; 2002; 12(5):485-7. PubMed ID: 12370142
[TBL] [Abstract][Full Text] [Related]
17. Sarcoidosis and pyoderma gangrenosum: an exceptional association. The role of trauma and immunosuppressive agents.
Herrero JE; Mascaró JM; Llambrich A; Herrero C
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):97-9. PubMed ID: 15649201
[TBL] [Abstract][Full Text] [Related]
18. Mooren's-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review.
Meskin SW; Carlson EM
Ocul Immunol Inflamm; 2011 Oct; 19(5):340-2. PubMed ID: 21823931
[TBL] [Abstract][Full Text] [Related]
19. Disseminated superficial porokeratosis and pyoderma gangrenosum.
di Meo N; Fluehler C; Perkan V; Trevisan G
Dermatol Online J; 2010 Oct; 16(10):15. PubMed ID: 21062609
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
